• OPEN AN ACCOUNT
Indian Indices
Sensex
72,119.76 -518.94
( -0.71%)
Global Indices
Nasdaq
51,194.40 -347.88
(-0.67%)
Dow Jones
7,822.15 -17.78
(-0.23%)
Hang Seng
70,229.08 -454.90
(-0.64%)
Nikkei 225
10,456.95 -84.74
(-0.80%)
Forex
USD-INR
96.37 0.10
(0.10%)
EUR-INR
108.33 0.45
(0.42%)
GBP-INR
127.68 0.44
(0.34%)
JPY-INR
0.61 0.00
(0.01%)

EQUITY - MARKET SCREENER

Frontier Capital Ltd
Industry :  Finance & Investments
BSE Code
ISIN Demat
Book Value()
508980
INE977E01013
-3.7674356
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
376.33
18.92
EPS(TTM)
Face Value()
Div & Yield %
0.03
10
0
 

Conart Engineers bags Rs 15 cr order from Apothecon Pharmaceuticals
May 27,2026
The contract involves civil construction work for LVAPI-6 services at PO Dabhasa, Padra, Vadodara district, Gujarat, and is scheduled to be executed within 12 months from the date of the purchase order.

The company stated that neither its promoters nor promoter group entities have any interest in the awarding authority, adding that the transaction does not qualify as a related-party transaction.

Conart Engineers is engaged in providing engineering, procurement, and construction (EPC) and contracting services for industrial, commercial, and infrastructure projects.

The company reported a 190.5% surge in consolidated net profit to Rs 0.61 crore on a 10.24% increase in revenue to Rs 15.61 crore in Q3 FY26 as compared with Q3 FY25.